Search for: "Becton v. United States" Results 101 - 115 of 115
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2009, 7:20 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US CAFC: Continuation limits invalid; limits on claims and RCEs are ok: Tafas v Doll (Patently-O) (Law360) (Hal Wegner) (IAM) (Patent Baristas) (Promote the Progress) (Patent Docs) (Patent Docs) (Patent Docs) (IP Spotlight) (Inventive Step) (IP Watchdog) (Washington State Patent Law Blog) (Anticipate This!) [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles)   Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
25 May 2011, 11:46 pm
United States, 429 U.S. 17 (1976), and Precision Instruments Manufacturing Co. v. [read post]
25 Jan 2008, 1:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:Chinese company Zhongyi Electronic sues Microsoft for alleged patent infringement relating to technology that converts Roman characters to Chinese characters: (Jurist), (China Hearsay), (IP Dragon),US Patent reform and surrounding controversy: general commentary and opinions: (Patent Baristas), (IPBiz), (IPBiz), (IPBiz), (Patent … [read post]
1 Nov 2008, 3:12 am
(IPKat) United States US General 2005 civil damages awards in state courts rarely broke $1M according to report released by US Justice Department (Law360) Changes to expert witness rules draws critisism (Law360) Collaborative law and intellectual property cases (The IP ADR Blog) Democrats victory could mean a new focus on civil suits (Law360) Election could drastically affect appeals court makeup (Law360) Ethics case survey: when is attorney-client privilege… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Nov 2010, 3:09 pm
Cancer Research sued Barr for patent infringement in the United States District Court for the District of Delaware on July 20, 2007. [read post]
25 Oct 2008, 12:18 am
(Class 46)   New Zealand Two for one in the House: Treaties and Anti-Counterfeiting Bill (International Law Office)   South Africa 'Softlifting' adds to South African piracy woes (Afro-IP)   Spain 'Theory of consumer error' rejected in criminal trade mark proceedings in Spain (Class 46)   Switzerland Swiss Federal Institute of Intellectual Property (IGE) reports progress in quest for improving legal protection for ‘Made in… [read post]
27 Jun 2011, 6:56 pm
("ACI") appeals from the final judgment of the United States District Court for the Southern District of California. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
9 Mar 2020, 1:21 pm by Unknown
Some state laws on this may also have to be addressed.Why are 11 of 26 biosimilars approved not actively marketed in the US? [read post]